STEPHEN FEINBERG

CIK 947822 · last filed 2025-02-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.10B

Companies

17

Total Filings

90

Lifetime Open-Market Net

-$883.80M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ACI Director 151,818,680 $12.01 $1.82B $0 2 2025-02-11
Cerberus Telecom Acquisition Corp. (CTAC.WS) Delisted Director $1.00 $0 1 2021-09-30
Cerberus Telecom Acquisition Corp. (CTAC.U) Delisted Director 800,000 $8.18 $6.54M $0 2 2020-12-07
ATEX 10%+ Owner 1,701,599 $99.26 $168.90M -$48.16M 2 2019-10-15
Anterix Inc. (PDVW) Delisted 10%+ Owner 2,887,407 $25.52M 27 2019-06-13
BXC 10%+ Owner 270,398 $89.88 $24.30M $27.02M 3 2017-10-23
BLBD 10%+ Owner 0 $68.76 $0 -$125.70M 2 2016-06-10
AVON PRODUCTS INC (AVP) Delisted 10%+ Owner $0 1 2016-04-04
Tower International, Inc. (TOWR) Delisted 10%+ Owner 1,579,744 -$229.00M 2 2013-11-08
DIGITALGLOBE, INC. (DGI) Delisted 10%+ Owner 5,486,429 -$141.50M 1 2013-03-11
GeoEye, Inc. (GEOY) Delisted 10%+ Owner 4,772,179 $92.04M 26 2012-08-09
Hawaiian Telcom Holdco, Inc. (HCOM) Delisted 10%+ Owner 840,442 $14.54 $12.22M -$297.5K 1 2011-09-09
BIOSPHERE MEDICAL INC (BSMD) Delisted 10%+ Owner 2,763,268 $0 2 2010-09-08
SSTI 10,762,583 $7.92 $85.24M $0 1 2010-03-26
Talecris Biotherapeutics Holdings Corp. (TLCR) Delisted 10%+ Owner 61,175,236 -$485.73M 1 2009-10-07
SCOTTISH RE GROUP LTD (SCT) Delisted 10%+ Owner $0 1 2007-06-07
Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted 10%+ Owner 3,753,306 $2.01M 8 2007-04-10

Recent Filings · Page 9 of 9

90 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2007-06-07 SCOTTISH RE GROUP LTD (SCT) Delisted Other (J) $0 EDGAR
2007-04-16 Sell (S) −5,406,113 -$648.7K
2007-04-10 Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted Buy (P) +12,642 $158.0K EDGAR
2007-04-02 Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted Buy (P) +7,409 $92.6K EDGAR
2007-03-30 Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted Buy (P) +5,199 $64.7K EDGAR
2007-03-01 Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted Buy (P) +200 $2.5K EDGAR
2007-02-27 Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted Buy (P) +1,754 $21.9K EDGAR
2007-02-22 Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted Buy (P) +12,396 $154.5K EDGAR
2007-02-20 Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted Buy (P) +10,400 $130.0K EDGAR
2007-02-05 Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted Mixed +3,703,306 $1.39M EDGAR
Showing 8190 of 90
Page 9 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.